Skip to main content

Table 2 Univariate analysis for biochemical relapse-free survival (bRFS) of patients with localized prostate cancer

From: Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer

Variate

5-year bRFS rate (%)

P value

Age (years)

 ≤ 72

91.8

0.57

 > 72

93.6

Gleason score

 ≤ 6

96.7

< 0.01

 7

93.5

 ≥ 8

79.3

T stage

 T1–T2b

94.1

< 0.01

 T2c

60.0

 ≥ T3

69.3

Pretreatment PSA level (mg/dL)

 ≤ 10

93.5

< 0.01

 > 10 and ≤ 20

95.2

 > 20

80.2

D’Amico risk category

 Low risk

96.9

< 0.01

 Intermediate risk

93.3

 High risk

82.0

ADT

 No

96.6

< 0.01

 Yes

90.7